<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03057691</url>
  </required_header>
  <id_info>
    <org_study_id>XJTU1AF-CRF-2016-004</org_study_id>
    <nct_id>NCT03057691</nct_id>
  </id_info>
  <brief_title>The Impact of Depression and/or Anxiety on PCI Patients</brief_title>
  <official_title>The Impact of Depression and/or Anxiety on Patients With Acute Coronary Syndrome After Percutaneous Coronary Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shaanxi Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Hospital of Xi An City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baoji Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Hospital of Ningxia Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The People's Hospital of Ningxia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuzhong City People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Xinjiang Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinjiang Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the First Division Hospital of Xinjiang Production and Construction Corps</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>First Affiliated Hospital Xi'an Jiaotong University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate how depression and/or anxiety could effect the
      prognosis of the patients post-ACS after PCI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial is a prospective, multi-centric, real-world clinical study. About 5,000 patients
      with ACS post-PCI will be recruited according to the resource available of each participating
      center to represent real-world setting. Patients enrolled in the project will accept
      two-years' follow-up and will be assessed on mortality, cardiovascular events, and severity
      of depressive or anxiety symptoms using self-rating scales continuously during the trial, in
      which their treatment for anxiety or depression will also be documented.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 11, 2017</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Cardiovascular Events</measure>
    <time_frame>From date of first visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 24 months</time_frame>
    <description>death, myocardial infarction, stroke, angina pectoris, revascularization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depression self-rating scales</measure>
    <time_frame>From date of first visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 24 months</time_frame>
    <description>results of depression scales assessed by The Patient Health Questionnaire-2 (PHQ-2, scores ≤2 non, &gt;2 continue PHQ-9) or PHQ-9 (scores ≤4 non, 5~9 mild, 10~19 mediate, ≥ 20 severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety self-rating scales</measure>
    <time_frame>From date of first visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 24 months</time_frame>
    <description>results of anxiety scales assessed by Generalized Anxiety Disorder 2-item(GAD-2, scores ≤2 non, &gt;2 continue GAD-7) or GAD-7 (scores ≤4 non, 5~9 mild, 10~14 mediate, ≥15 severe)</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>No depression/anxiety</arm_group_label>
    <description>patients suffered from ACS who have undergone PCI without depression or anxiety</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Depression</arm_group_label>
    <description>patients suffered from post-ACS depression who have undergone PCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anxiety</arm_group_label>
    <description>patients suffered from post-ACS anxiety who have undergone PCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Depression with anxiety</arm_group_label>
    <description>patients suffered from post-ACS depression with anxiety who have undergone PCI</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>antidepressive and anti-anxiety therapy</intervention_name>
    <description>These therapies include antidepressants, antianxiety drugs and psychotherapy. Subjects choose the therapy follow their own will. All of the above-mentioned therapies are identified by experienced psychiatrists in the same center. The treatment information will be recorded in each visit. The study is considered non-interventional, and no antidepressive or anti-anxiety therapies are mandated.</description>
    <arm_group_label>Anxiety</arm_group_label>
    <arm_group_label>Depression</arm_group_label>
    <arm_group_label>Depression with anxiety</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients suffered from acute coronary syndrome after percutaneous coronary
        intervention
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria

        1. Aged &gt; 18 years old 2. Patients with a diagnosis of ACS including acute myocardial
        infarction (MI) and unstable angina (UA). Acute MI diagnosis must be met with at least two
        of these following criteria: typical chest pain, abnormal elevation of cardiac biomarkers,
        and electrocardiographic changes consist with MI. The diagnosis of UA includes new onset
        angina within 1 month, crescendo angina, resting angina, infarction angina, and variant
        angina.

        3. Good recovery from PCI. 4. Volunteer for the study and sign the informed consent.
        Exclusion Criteria

          1. Severe heart failure, defined as left ventricular ejection fraction (LVEF)≤30% or New
             York Heart Association (NYHA) class≥III.

          2. Severe renal dysfunction, defined as creatinine clearance rate ≤30 ml/min.

          3. Cancer.

          4. Other severe mental illness including schizophrenia, severe dementia, substance abuse,
             etc.

          5. Bipolar disorder.

          6. Ongoing administration of antipsychotic, antidepressant, or antianxiety drugs.

          7. Serious risk of suicide.

          8. Severe, life-threatening medical condition (patients cannot participate in the study
             course).

          9. Pregnancy and lactation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zuyi Yuan, Professor</last_name>
    <role>Study Director</role>
    <affiliation>First Affiliated Hospital Xi'an Jiaotong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan Zhou, Professor</last_name>
    <phone>0086-18191037350</phone>
    <email>1306899042@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wenyuan Li</last_name>
    <phone>0086-15191903966</phone>
    <email>lc3xlwy@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Affiliated Hospital of Xi'an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Zhou, Professor</last_name>
      <phone>0086-18191037350</phone>
      <email>1306899042@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Teply RM, Packard KA, White ND, Hilleman DE, DiNicolantonio JJ. Treatment of Depression in Patients with Concomitant Cardiac Disease. Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):514-28. doi: 10.1016/j.pcad.2015.11.003. Epub 2015 Nov 10. Review.</citation>
    <PMID>26562328</PMID>
  </reference>
  <reference>
    <citation>Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L; American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014 Mar 25;129(12):1350-69. doi: 10.1161/CIR.0000000000000019. Epub 2014 Feb 24. Review.</citation>
    <PMID>24566200</PMID>
  </reference>
  <reference>
    <citation>Oldroyd JC, Cyril S, Wijayatilaka BS, O'Neil A, McKenzie DP, Zavarsek S, Sanderson K, Hare DL, Fisher AJ, Forbes AB, Barr Taylor C, Clarke DM, Meredith IT, Oldenburg B. Evaluating the impact of depression, anxiety &amp; autonomic function on health related quality of life, vocational functioning and health care utilisation in acute coronary syndrome patients: the ADVENT study protocol. BMC Cardiovasc Disord. 2013 Nov 17;13:103. doi: 10.1186/1471-2261-13-103.</citation>
    <PMID>24237848</PMID>
  </reference>
  <reference>
    <citation>Regan KL. Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review. J Cardiovasc Nurs. 2008 Nov-Dec;23(6):489-96. doi: 10.1097/01.JCN.0000338929.89210.af. Review.</citation>
    <PMID>18953212</PMID>
  </reference>
  <reference>
    <citation>Ossola P, Paglia F, Pelosi A, De Panfilis C, Conte G, Tonna M, Ardissino D, Marchesi C. Risk factors for incident depression in patients at first acute coronary syndrome. Psychiatry Res. 2015 Aug 30;228(3):448-53. doi: 10.1016/j.psychres.2015.05.063. Epub 2015 Jun 27.</citation>
    <PMID>26144582</PMID>
  </reference>
  <reference>
    <citation>Huffman JC, Celano CM, Januzzi JL. The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes. Neuropsychiatr Dis Treat. 2010 May 6;6:123-36.</citation>
    <PMID>20505844</PMID>
  </reference>
  <reference>
    <citation>Celano CM, Millstein RA, Bedoya CA, Healy BC, Roest AM, Huffman JC. Association between anxiety and mortality in patients with coronary artery disease: A meta-analysis. Am Heart J. 2015 Dec;170(6):1105-15. doi: 10.1016/j.ahj.2015.09.013. Epub 2015 Sep 21. Review.</citation>
    <PMID>26678632</PMID>
  </reference>
  <reference>
    <citation>Nezafati MH, Vojdanparast M, Nezafati P. Antidepressants and cardiovascular adverse events: A narrative review. ARYA Atheroscler. 2015 Sep;11(5):295-304. Review.</citation>
    <PMID>26715935</PMID>
  </reference>
  <reference>
    <citation>Marke V, Bennett P. Predicting negative emotional states following first onset acute coronary syndrome. J Health Psychol. 2017 May;22(6):765-775. doi: 10.1177/1359105315614996. Epub 2015 Nov 26.</citation>
    <PMID>26613707</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>February 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2017</study_first_posted>
  <last_update_submitted>November 14, 2018</last_update_submitted>
  <last_update_submitted_qc>November 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Coronary Syndrome</keyword>
  <keyword>Depression</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Major Adverse Cardiovascular Events</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

